1
BRISTOL-MYERS SQUIBB CO
COM
BMY
BMY
1,376,436
$57.2m26.45%
26.45%
Reduced Shares held: Q3 2023 1.4m, Q4 2023 1.4m, Q1 2024 1.4m, Q2 2024 1.4m
-30.8k
-30,776
-2.2%
2
BIODESIX INC
COM
COM
11,237,289
$17.2m7.94%
7.94%
Added Shares held: Q3 2023 10.5m, Q4 2023 10.5m, Q1 2024 10.5m, Q2 2024 11.2m
+695.7k
+695,680
6.6%
3
ELUTIA INC
CL A COM
ELUT
ELUT
3,103,310
$15.4m7.12%
7.12%
Reduced Shares held: Q3 2023 3.3m, Q4 2023 3.3m, Q1 2024 3.3m, Q2 2024 3.1m
-207.1k
-207,058
-6.2%
4
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
84,480
$11.6m5.38%
5.38%
Reduced Shares held: Q3 2023 154.5k, Q4 2023 154.5k, Q1 2024 154.5k, Q2 2024 84.5k
-70.0k
-70,000
-45.3%
5
SILK RD MED INC
COM
SILK
SILK
316,188
$8.5m3.96%
3.96%
Unchanged Shares held: Q3 2023 82.6k, Q4 2023 316.2k, Q1 2024 316.2k, Q2 2024 316.2k
6
PROTHENA CORP PLC
SHS
PRTA
PRTA
407,148
$8.4m3.89%
3.89%
Added Shares held: Q3 2023 339.1k, Q4 2023 339.1k, Q1 2024 339.1k, Q2 2024 407.1k
+68.0k
+68,000
20.1%
7
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
500,800
$8.1m3.76%
3.76%
Unchanged Shares held: Q3 2023 480.8k, Q4 2023 480.8k, Q1 2024 500.8k, Q2 2024 500.8k
8
OVINTIV INC
COM
OVV
OVV
148,400
$7.0m3.22%
3.22%
Reduced Shares held: Q3 2023 168.4k, Q4 2023 168.4k, Q1 2024 168.4k, Q2 2024 148.4k
-20.0k
-20,000
-11.9%
9
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
20,000
$6.4m2.95%
2.95%
Reduced Shares held: Q3 2023 22.0k, Q4 2023 22.0k, Q1 2024 22.0k, Q2 2024 20.0k
-2.0k
-2,000
-9.1%
10
HARROW INC
COM
HROW
HROW
300,000
$6.3m2.90%
2.90%
Unchanged Shares held: Q3 2023 300.0k, Q4 2023 300.0k, Q1 2024 300.0k, Q2 2024 300.0k
11
STOKE THERAPEUTICS INC
COM
STOK
STOK
420,000
$5.7m2.63%
2.63%
Unchanged Shares held: Q3 2023 170.0k, Q4 2023 420.0k, Q1 2024 420.0k, Q2 2024 420.0k
12
PHREESIA INC
COM
PHR
PHR
229,400
$4.9m2.25%
2.25%
Unchanged Shares held: Q3 2023 165.4k, Q4 2023 229.4k, Q1 2024 229.4k, Q2 2024 229.4k
13
CORCEPT THERAPEUTICS INC
COM
CORT
CORT
148,000
$4.8m2.22%
2.22%
Added Shares held: Q3 2023 100.0k, Q4 2023 100.0k, Q1 2024 100.0k, Q2 2024 148.0k
+48.0k
+48,000
48.0%
14
QUIDEL CORP
COM
QDEL
QDEL
135,238
$4.5m2.08%
2.08%
Added Shares held: Q3 2023 130.4k, Q4 2023 130.4k, Q1 2024 130.4k, Q2 2024 135.2k
+4.8k
+4,832
3.7%
15
MASIMO CORP
COM
MASI
MASI
30,560
$3.8m1.78%
1.78%
Unchanged Shares held: Q3 2023 30.6k, Q4 2023 30.6k, Q1 2024 30.6k, Q2 2024 30.6k
16
FOGHORN THERAPEUTICS INC
COM
FHTX
FHTX
641,860
$3.7m1.71%
1.71%
Unchanged Shares held: Q3 2023 529.7k, Q4 2023 641.9k, Q1 2024 641.9k, Q2 2024 641.9k
17
EQUITRANS MIDSTREAM CORP
COM
ETRN
ETRN
266,100
$3.5m1.60%
1.60%
Unchanged Shares held: Q3 2023 266.1k, Q4 2023 266.1k, Q1 2024 266.1k, Q2 2024 266.1k
18
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
96,000
$3.3m1.54%
1.54%
Unchanged Shares held: Q3 2023 76.0k, Q4 2023 96.0k, Q1 2024 96.0k, Q2 2024 96.0k
19
AXOGEN INC
COM
AXGN
AXGN
394,000
$2.9m1.32%
1.32%
Added Shares held: Q3 2023 346.0k, Q4 2023 346.0k, Q1 2024 346.0k, Q2 2024 394.0k
+48.0k
+48,000
13.9%
20
DOCGO INC
COM
DCGO
DCGO
920,000
$2.8m1.32%
1.32%
Unchanged Shares held: Q3 2023 260.0k, Q4 2023 300.0k, Q1 2024 920.0k, Q2 2024 920.0k
21
ALKERMES PLC
SHS
ALKS
ALKS
100,000
$2.4m1.11%
1.11%
Unchanged Shares held: Q3 2023 100.0k, Q4 2023 100.0k, Q1 2024 100.0k, Q2 2024 100.0k
22
TRAVERE THERAPEUTICS INC
COM
TVTX
TVTX
244,000
$2.0m0.93%
0.93%
Unchanged Shares held: Q3 2023 164.0k, Q4 2023 244.0k, Q1 2024 244.0k, Q2 2024 244.0k
23
ALPHATEC HLDGS INC
COM NEW
ATEC
ATEC
176,000
$1.8m0.85%
0.85%
Unchanged Shares held: Q3 2023 160.0k, Q4 2023 176.0k, Q1 2024 176.0k, Q2 2024 176.0k
24
CASTLE BIOSCIENCES INC
COM
CSTL
CSTL
68,000
$1.5m0.68%
0.68%
Added Shares held: Q3 2023 0, Q4 2023 20.0k, Q1 2024 28.0k, Q2 2024 68.0k
+40.0k
+40,000
142.9%
25
EXXON MOBIL CORP
COM
XOM
XOM
11,698
$1.3m0.62%
0.62%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 11.7k
26
PROGYNY INC
COM
PGNY
PGNY
44,000
$1.3m0.58%
0.58%
Unchanged Shares held: Q3 2023 36.0k, Q4 2023 44.0k, Q1 2024 44.0k, Q2 2024 44.0k
27
10X GENOMICS INC
CL A COM
TXG
TXG
60,000
$1.2m0.54%
0.54%
Unchanged Shares held: Q3 2023 42.0k, Q4 2023 60.0k, Q1 2024 60.0k, Q2 2024 60.0k
28
KINIKSA PHARMACEUTICALS LTD
COM CL A
COM CL A
60,000
$1.1m0.52%
0.52%
Unchanged Shares held: Q3 2023 60.0k, Q4 2023 60.0k, Q1 2024 60.0k, Q2 2024 60.0k
29
KALVISTA PHARMACEUTICALS INC
COM
KALV
KALV
92,000
$1.1m0.50%
0.50%
Unchanged Shares held: Q3 2023 80.0k, Q4 2023 80.0k, Q1 2024 92.0k, Q2 2024 92.0k
30
CYTOKINETICS INC
COM NEW
CYTK
CYTK
20,000
$1.1m0.50%
0.50%
Unchanged Shares held: Q3 2023 50.0k, Q4 2023 50.0k, Q1 2024 20.0k, Q2 2024 20.0k
31
APELLIS PHARMACEUTICALS INC
COM
APLS
APLS
28,000
$1.1m0.50%
0.50%
Reduced Shares held: Q3 2023 36.0k, Q4 2023 36.0k, Q1 2024 36.0k, Q2 2024 28.0k
-8.0k
-8,000
-22.2%
32
HALOZYME THERAPEUTICS INC
COM
HALO
HALO
20,000
$1.0m0.48%
0.48%
Unchanged Shares held: Q3 2023 20.0k, Q4 2023 20.0k, Q1 2024 20.0k, Q2 2024 20.0k
33
COHERUS BIOSCIENCES INC
COM
CHRS
CHRS
540,000
$934.2k0.43%
0.43%
Unchanged Shares held: Q3 2023 0, Q4 2023 220.0k, Q1 2024 540.0k, Q2 2024 540.0k
34
KARYOPHARM THERAPEUTICS INC
COM
COM
939,664
$815.3k0.38%
0.38%
Unchanged Shares held: Q3 2023 1.1m, Q4 2023 939.7k, Q1 2024 939.7k, Q2 2024 939.7k
35
ARVINAS INC
COM
ARVN
ARVN
30,000
$798.6k0.37%
0.37%
Unchanged Shares held: Q3 2023 30.0k, Q4 2023 30.0k, Q1 2024 30.0k, Q2 2024 30.0k
36
SAREPTA THERAPEUTICS INC
COM
SRPT
SRPT
5,000
$790.0k0.37%
0.37%
Unchanged Shares held: Q3 2023 5.0k, Q4 2023 5.0k, Q1 2024 5.0k, Q2 2024 5.0k
37
XENON PHARMACEUTICALS INC
COM
XENE
XENE
20,000
$779.8k0.36%
0.36%
Unchanged Shares held: Q3 2023 20.0k, Q4 2023 20.0k, Q1 2024 20.0k, Q2 2024 20.0k
38
ACCELERATE DIAGNOSTICS INC
COM
COM
650,478
$761.1k0.35%
0.35%
Unchanged Shares held: Q3 2023 450.5k, Q4 2023 450.5k, Q1 2024 650.5k, Q2 2024 650.5k
39
SPRINGWORKS THERAPEUTICS INC
COM
SWTX
SWTX
20,000
$753.4k0.35%
0.35%
Unchanged Shares held: Q3 2023 0, Q4 2023 20.0k, Q1 2024 20.0k, Q2 2024 20.0k
40
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
40,000
$697.6k0.32%
0.32%
Reduced Shares held: Q3 2023 50.2k, Q4 2023 50.2k, Q1 2024 50.2k, Q2 2024 40.0k
-10.2k
-10,228
-20.4%
41
NOVOCURE LTD
ORD SHS
NVCR
NVCR
40,000
$685.2k0.32%
0.32%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 40.0k
42
AXSOME THERAPEUTICS INC
COM
AXSM
AXSM
8,000
$644.0k0.30%
0.30%
Unchanged Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 8.0k, Q2 2024 8.0k
43
KEROS THERAPEUTICS INC
COM
KROS
KROS
14,000
$639.8k0.30%
0.30%
Unchanged Shares held: Q3 2023 14.0k, Q4 2023 14.0k, Q1 2024 14.0k, Q2 2024 14.0k
44
BLUEBIRD BIO INC
COM
COM
622,400
$612.6k0.28%
0.28%
Reduced Shares held: Q3 2023 910.4k, Q4 2023 642.4k, Q1 2024 642.4k, Q2 2024 622.4k
-20.0k
-20,000
-3.1%
45
AMICUS THERAPEUTICS INC
COM
FOLD
FOLD
56,000
$555.5k0.26%
0.26%
Unchanged Shares held: Q3 2023 56.0k, Q4 2023 56.0k, Q1 2024 56.0k, Q2 2024 56.0k
46
BIOHAVEN PHARMACTL HLDG CO L
COM
BHVN
BHVN
14,730
$511.3k0.24%
0.24%
Unchanged Shares held: Q3 2023 0, Q4 2023 14.7k, Q1 2024 14.7k, Q2 2024 14.7k
47
BIOCRYST PHARMACEUTICALS INC
COM
BCRX
BCRX
80,000
$494.4k0.23%
0.23%
Added Shares held: Q3 2023 40.0k, Q4 2023 40.0k, Q1 2024 40.0k, Q2 2024 80.0k
+40.0k
+40,000
100.0%
48
XENCOR INC
COM
XNCR
XNCR
24,600
$465.7k0.22%
0.22%
Unchanged Shares held: Q3 2023 24.6k, Q4 2023 24.6k, Q1 2024 24.6k, Q2 2024 24.6k
49
WAVE LIFE SCIENCES LTD
SHS
96663EUR
96663EUR
80,000
$399.2k0.18%
0.18%
Unchanged Shares held: Q3 2023 0, Q4 2023 80.0k, Q1 2024 80.0k, Q2 2024 80.0k
50
G1 THERAPEUTICS INC
COM
GTHX
GTHX
160,000
$364.8k0.17%
0.17%
Unchanged Shares held: Q3 2023 240.0k, Q4 2023 160.0k, Q1 2024 160.0k, Q2 2024 160.0k
51
INHIBRX BIOSCIENCES INC
COM
INBX
INBX
24,220
$341.2k0.16%
0.16%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 24.2k
52
GOSSAMER BIO INC
COM
GOSS
GOSS
276,352
$249.0k0.12%
0.12%
Unchanged Shares held: Q3 2023 418.2k, Q4 2023 276.4k, Q1 2024 276.4k, Q2 2024 276.4k
53
LIQUIDIA CORPORATION
COM NEW
LQDA
LQDA
20,000
$240.0k0.11%
0.11%
Unchanged Shares held: Q3 2023 0, Q4 2023 40.0k, Q1 2024 20.0k, Q2 2024 20.0k
54
INFLARX NV
COM
IFRX
IFRX
100,000
$174.0k0.08%
0.08%
Unchanged Shares held: Q3 2023 100.0k, Q4 2023 100.0k, Q1 2024 100.0k, Q2 2024 100.0k
55
CABALETTA BIO INC
COM
CABA
CABA
20,000
$149.6k0.07%
0.07%
Unchanged Shares held: Q3 2023 0, Q4 2023 20.0k, Q1 2024 20.0k, Q2 2024 20.0k
56
2SEVENTY BIO INC
COMMON STOCK
TSVT
TSVT
35,666
$137.3k0.06%
0.06%
Reduced Shares held: Q3 2023 119.7k, Q4 2023 39.7k, Q1 2024 39.7k, Q2 2024 35.7k
-4.0k
-4,000
-10.1%
57
VENTYX BIOSCIENCES INC
COM
VTYX
VTYX
57,600
$133.1k0.06%
0.06%
Unchanged Shares held: Q3 2023 52.8k, Q4 2023 57.6k, Q1 2024 57.6k, Q2 2024 57.6k
58
ZENTALIS PHARMACEUTICALS INC
COM
ZNTL
ZNTL
32,000
$130.9k0.06%
0.06%
Unchanged Shares held: Q3 2023 0, Q4 2023 32.0k, Q1 2024 32.0k, Q2 2024 32.0k
59
OUTSET MED INC
COM
OM
OM
20,000
$77.0k0.04%
0.04%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 20.0k
60
PHOENIX BIOTECH ACQUISITION
CLASS A COM
CLASS A COM
25,944
$7.8k0.00%
0.00%
Unchanged Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 25.9k, Q2 2024 25.9k